Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Inxmed (shanghai) Co., Ltd.

Clinical trials sponsored by Inxmed (shanghai) Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug IN10028 tested for advanced cancers Results expected Feb 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New drug IN10028 tested for advanced cancers

Disease control Not yet recruiting

This early-phase study tests a new drug called IN10028 in 75 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug shrinks tumors when used alone or with other cancer drugs. Th…

Phase 1 • Sponsor: InxMed (Shanghai) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:35 UTC